Loading insider details...
Latest Form 4 (Jan 6, 2026): Tender of Shares of 578 MRSN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jan 6, 2026 | Mersana Therapeutics, Inc. (MRSN) | Tender of Shares | 578 | n/a |
| Jun 13, 2025 | Mersana Therapeutics, Inc. (MRSN) | Grant/Award | 61,500 | n/a |
| Dec 13, 2024 | Nuvalent, Inc. (NUVL) | Sale | 1,250,000 | $110.00M |
| Jun 14, 2024 | Nuvalent, Inc. (NUVL) | Grant/Award | 2,499 | n/a |
| Jun 12, 2024 | Mersana Therapeutics, Inc. (MRSN) | Grant/Award | 55,000 | n/a |
| Mar 29, 2024 | Nuvalent, Inc. (NUVL) | Sale | 88,205 | $6.78M |
| Aug 10, 2023 | DYNAVAX TECHNOLOGIES CORP (DVAX) | Sale | 1,500,000 | $21.59M |
| Jun 16, 2023 | Nuvalent, Inc. (NUVL) | Grant/Award | 15,000 | n/a |
| Jun 16, 2023 | DYNAVAX TECHNOLOGIES CORP (DVAX) | Sale | 500,000 | $6.34M |
| Jun 12, 2023 | Mersana Therapeutics, Inc. (MRSN) | Grant/Award | 14,467 | n/a |